Brazil Gout Therapeutics Market Size & Outlook, 2023-2030

The gout therapeutics market in Brazil is expected to reach a projected revenue of US$ 81.2 million by 2030. A compound annual growth rate of 5.5% is expected of Brazil gout therapeutics market from 2024 to 2030.
Revenue, 2023 (US$M)
$55.9
Forecast, 2030 (US$M)
$81.2
CAGR, 2024 - 2030
5.5%
Report Coverage
Brazil

Brazil gout therapeutics market highlights

  • The Brazil gout therapeutics market generated a revenue of USD 55.9 million in 2023 and is expected to reach USD 81.2 million by 2030.
  • The Brazil market is expected to grow at a CAGR of 5.5% from 2024 to 2030.
  • In terms of segment, nsaids was the largest revenue generating drug class in 2023.
  • Urate lowering agents is the most lucrative drug class segment registering the fastest growth during the forecast period.


Gout therapeutics market data book summary

Market revenue in 2023USD 55.9 million
Market revenue in 2030USD 81.2 million
Growth rate5.5% (CAGR from 2023 to 2030)
Largest segmentNsaids
Fastest growing segmentUrate lowering agents
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNSAIDs, Corticosteroids (Prednisone), Colchicine, Urate lowering agents
Key market players worldwideTakeda Pharmaceutical Co Ltd, Novartis AG ADR, Regeneron Pharmaceuticals Inc, AstraZeneca PLC, Horizons International, Merck & Co Inc, Teijin Ltd, GlaxoSmithKline, Zydus Lifesciences


Other key industry trends

  • In terms of revenue, Brazil accounted for 2.1% of the global gout therapeutics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil gout therapeutics market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 81.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Gout Therapeutics Market Scope

Gout therapeutics market segmentation & scope
NSAIDs
Corticosteroids (Prednisone)
Colchicine
Urate lowering agents
Others
Acute
Chronic
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Gout Therapeutics Market Companies

Name Profile # Employees HQ Website

Brazil gout therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gout therapeutics market will help companies and investors design strategic landscapes.


Nsaids was the largest segment with a revenue share of 42.75% in 2023. Horizon Databook has segmented the Brazil gout therapeutics market based on nsaids, corticosteroids (prednisone), colchicine, urate lowering agents covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Brazil gout therapeutics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil gout therapeutics market databook

  • Our clientele includes a mix of gout therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil gout therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil gout therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Brazil gout therapeutics market size, by drug class, 2018-2030 (US$M)

Brazil Gout Therapeutics Market Outlook Share, 2023 & 2030 (US$M)

Brazil gout therapeutics market size, by drug class, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more